BRCA2 and cancer: Thus, considering prior myelotoxicity and the expected enhanced sensitivity to radiotherapy in BRCA2 mutant cancer, the patient underwent a long-course definitive imaging-guided radiotherapy (IGRT) for a total dose of 53.75 Gy in 25 fractions leading to a complete remission.